Spiro[1,2,4-benzotriazine-3(4H),4′-(1′-substituted)piperidines] and related compounds as ligands for sigma receptors

被引:18
作者
Novelli, F [1 ]
Sparatore, F [1 ]
机构
[1] Univ Genoa, Dipartimento Sci Farmaceut, I-16132 Genoa, Italy
来源
FARMACO | 2002年 / 57卷 / 11期
关键词
3,4-dihydro-1,2,4-benzotriazine derivatives; spiro compounds; sigma receptors ligands;
D O I
10.1016/S0014-827X(02)01293-4
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
As analogues of some conformationally restricted spiropiperidine derivatives which are endowed with high affinity for sigma(1), receptor, a set of 16 spiro[1,2,4-benzotriazine-3(4H),4'-(1'-substituted)piperidines] and congeneric compounds was prepared and tested for affinity to a, receptor subtype. All N-arylalkyl substituted derivatives exhibited high affinity for the relevant receptor, with K-i in the low nanomolar range. Affinity for sigma(2) subtype (assayed only for a few representative compounds) was from one to three order of magnitude lower. Spiro[ 1,2,4-benzotriazine-3(4H),4'-(1'-benzyl)piperidine] (2), with a ratio K(i)sigma(2)/K(j)sigma(1) = 7000 should represent the most selective sigma(1), ligand so far described. (C) 2002 Editions scientifiques et medicales Elsevier SAS. All rights reserved.
引用
收藏
页码:871 / 882
页数:12
相关论文
共 44 条
[11]  
GEIGY JR, 1966, CHEM ABSTR, V64
[12]  
GEIGY JR, 1965, Patent No. 660763
[13]   PIPERIDINYLTETRALIN SIGMA-LIGANDS [J].
GILLIGAN, PJ ;
KERGAYE, AA ;
LEWIS, BM ;
MCELROY, JF .
JOURNAL OF MEDICINAL CHEMISTRY, 1994, 37 (03) :364-370
[14]   NOVEL PIPERIDINE SIGMA RECEPTOR LIGANDS AS POTENTIAL ANTIPSYCHOTIC-DRUGS [J].
GILLIGAN, PJ ;
CAIN, GA ;
CHRISTOS, TE ;
COOK, L ;
DRUMMOND, S ;
JOHNSON, AL ;
KERGAYE, AA ;
MCELROY, JF ;
ROHRBACH, KW ;
SCHMIDT, WK ;
TAM, SW .
JOURNAL OF MEDICINAL CHEMISTRY, 1992, 35 (23) :4344-4361
[15]   STRUCTURAL FEATURES IMPORTANT FOR SIGMA(1) RECEPTOR-BINDING [J].
GLENNON, RA ;
ABLORDEPPEY, SY ;
ISMAIEL, AM ;
ELASHMAWY, MB ;
FISCHER, JB ;
HOWIE, KB .
JOURNAL OF MEDICINAL CHEMISTRY, 1994, 37 (08) :1214-1219
[16]   CLONING OF THE CDNA AND GENE FOR A HUMAN D2-DOPAMINE RECEPTOR [J].
GRANDY, DK ;
MARCHIONNI, MA ;
MAKAM, H ;
STOFKO, RE ;
ALFANO, M ;
FROTHINGHAM, L ;
FISCHER, JB ;
BURKEHOWIE, KJ ;
BUNZOW, JR ;
SERVER, AC ;
CIVELLI, O .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (24) :9762-9766
[17]   Involvement of σreceptors in the modulation of the glutamatergic/NMDA neurotransmission in the dopaminergic systems [J].
Gronier, B ;
Debonnel, G .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1999, 368 (2-3) :183-196
[18]  
Guareschi I., 1895, BER, V28, P160
[19]  
Guareschi I., 1894, Atti R. Accad. Sci. Torino, P680
[20]  
Guitart X., 1998, CNS Drug Reviews, V4, P201, DOI 10.1111/j.1527-3458.1998.tb00065.x